Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Criteria for Switching New Molecular Entities from Prescription to Over-the-Counter

Therapeutic Innovation & Regulatory Science

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Other

First published online January, 1990

Criteria for Switching New Molecular Entities from Prescription to Over-the-Counter

Volume 24, Issue 1

https://doi.org/10.1177/009286159002400106

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Degeneration and Dysfunction of Retinal Neurons in Acute Ocular Hypertensive Rats: Involvement of Calpains

Retricted access

i Drugs and i Devices Discovery Research: Preclinical Assays,Techniques,and Animal Model Studies for Ocular Hypotensives and Neuroprotectants

Retricted access

Eyes on New Product Development

Retricted access

The Effects of Commercially Available Preservative-Free FDA-Approved Triamcinolone (Triesence ® ) on Retinal Cells in Culture